Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WWP1 antisense RNA 1 (WWP1-AS1) is a human gene annotated as a long non-coding RNA (lncRNA), with the Ensembl ID ENSG00000254231 and NCBI Gene ID 105375624[7][8][10]. It is an RNA gene transcribed from the DNA strand antisense to the WWP1 coding region on chromosome 8, but its specific biological function, mechanisms, and disease associations remain uncharacterized in primary sources and gene compendia as of September 2025. WWP1-AS1 is distinct from the protein-coding gene WWP1, which encodes a well-studied E3 ubiquitin ligase; there is no indication that WWP1-AS1 itself acts as a receptor, enzyme, transporter, or therapeutic target[7][8][10]. Due to limited experimental evidence or literature describing its role, WWP1-AS1 should not be currently classified as a canonical therapeutic target, nor is there evidence of associated interacting drugs or biomarker use in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WWP1 antisense RNA 1 (WWP1-AS1).